Stockreport

Keros Therapeutics to Host a Corporate Update Conference Call and Webcast

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF LEXINGTON, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused [Read more]